FCM
CHE icon

Fieldview Capital Management’s Chemed CHE Stock Holding History

Fieldview Capital Management’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-879
Closed -$394K – 503
2025
Q3 		$394K Buy
+879
New +$398K 0.06% 291
2025
Q2 		– Sell
-5,292
Closed -$3.26M – 368
2025
Q1 		$3.26M Buy
+5,292
New +$3.01M 0.46% 71

Other funds holding CHE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Fieldview Capital Management's CHE Position: Q4 2025 in Review

Fieldview Capital Management sold out of Chemed (CHE) in Q4 2025, closing a stake of 879 shares — an estimated $394K sold.

Fieldview Capital Management first reported a position in CHE in Q1 2025 and held it in 2 quarters. The position peaked at $3.26M in Q1 2025. 518 funds tracked by Wall St. Rank hold CHE as of Q4 2025.

  • Fieldview Capital Management reported no remaining Chemed position as of Q4 2025 after selling out during the quarter.
  • Fieldview Capital Management sold 879 Chemed shares in Q4 2025, an estimated $394K.
  • Fieldview Capital Management first reported a position in Chemed in Q1 2025 and held it in 2 quarters.
  • Fieldview Capital Management's Chemed position peaked at $3.26M in Q1 2025.
  • 518 funds tracked by Wall St. Rank held Chemed as of Q4 2025.

Based on Fieldview Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.